Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome—A Randomized Controlled Trial

Sympathetic nervous system (SNS) activity is increased in polycystic ovary syndrome (PCOS). Moxonidine is a centrally acting sympatholytic drug with known beneficial effects on hypertension, insulin sensitivity, dyslipidemia and inflammation. In this double-blind placebo controlled randomized clinic...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Soulmaz Shorakae, Elisabeth A. Lambert, Eveline Jona, Carolina Ika Sari, Barbora de Courten, John B. Dixon, Gavin W. Lambert, Helena J. Teede
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2018-10-01
Serie:	Frontiers in Physiology
Soggetti:	polycystic ovary syndrome sympathetic nervous system insulin resistance moxonidine randomized controlled trial
Accesso online:	https://www.frontiersin.org/article/10.3389/fphys.2018.01486/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!